Davies P H, Sheppard M C, Franklyn J A
Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, UK.
Mol Cell Endocrinol. 1997 May 16;129(2):191-8. doi: 10.1016/s0303-7207(97)04058-6.
Administration of tumour necrosis factor-alpha (TNF alpha), interleukin-1beta (IL-1beta) and interleukin-6 (IL-6) to animals and humans results in changes in circulating thyroid hormone concentrations similar to those seen in non-thyroidal illness (NTI). Inflammatory cytokines have been postulated as mediators of the euthyroid sick syndrome by inhibiting type 1 5'-deiodinase (5'D-I) enzyme activity. We have investigated direct effects of cytokines upon 5'D-I expression, measuring changes in 5'D-I enzyme activity and mRNA in phi1 rat liver cells. All three cytokines stimulated 5'D-I enzyme activity: TNF alpha 326 +/- 43% (100% in controls, mean + S.E.M., n = 9, P < 0.01 by ANOVA), IL-1beta 297 +/- 8% and IL-6 272 +/- 25%. Co-incubation with cycloheximide abolished stimulation by each cytokine. Kinetic analysis revealed that stimulation of 5'D-I enzyme activity was a result of significantly increased Vmax, (P < 0.01 by ANOVA) with Km relatively unchanged. 5'D-I mRNA abundance was not significantly changed following treatment by any of the three cytokines. These findings do not support the hypothesis that inflammatory cytokines may mediate the euthyroid sick syndrome by causing inhibition of 5'D-I activity.
给动物和人类注射肿瘤坏死因子-α(TNFα)、白细胞介素-1β(IL-1β)和白细胞介素-6(IL-6)会导致循环甲状腺激素浓度发生变化,类似于在非甲状腺疾病(NTI)中所见。炎症细胞因子被认为是通过抑制1型5'-脱碘酶(5'D-I)的酶活性来介导正常甲状腺病态综合征的介质。我们研究了细胞因子对5'D-I表达的直接影响,测量了phi1大鼠肝细胞中5'D-I酶活性和mRNA的变化。所有三种细胞因子均刺激了5'D-I酶活性:TNFα为326±43%(对照组为100%,平均值±标准误,n = 9,方差分析P < 0.01),IL-1β为297±8%,IL-6为272±25%。与放线菌酮共同孵育消除了每种细胞因子的刺激作用。动力学分析表明,5'D-I酶活性的刺激是Vmax显著增加的结果(方差分析P < 0.01),而Km相对不变。三种细胞因子中的任何一种处理后,5'D-I mRNA丰度均无显著变化。这些发现不支持炎症细胞因子可能通过抑制5'D-I活性来介导正常甲状腺病态综合征的假说。